Covid Vaccine: expert panel proposed approval of the emergency measures and use reserved for COVAXIN India
The Oxford COVID-19 vaccine manufactured by the Serum Institute of India has been cleared by a government-appointed panel and (DCGI) Bharat
The trial process of India’s first coronavirus vaccine — Covishield is to be completed in next 58 days and it will be commercialised in 73 days India
